We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
37 hedge funds and large institutions have $9.54M invested in Regulus Therapeutics in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
6,900% more call options, than puts
Call options by funds: $70K | Put options by funds: $1K
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
0.57% less ownership
Funds ownership: 2.64% → 2.07% (-0.57%)
10% less funds holding
Funds holding: 41 → 37 (-4)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
40% less capital invested
Capital invested by funds: $15.9M → $9.54M (-$6.32M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
37
Holders Change
-4
Holders Change %
-9.76%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
8
Reduced
8
Closed
10
Calls
$70K
Puts
$1K
Net Calls
+$69K
Net Calls Change
-$88K
Top Buyers
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$2.47M |
| 2 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$591K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$65.1K |
| 4 |
Two Sigma Advisers
New York
|
+$61.9K |
| 5 |
Two Sigma Investments
New York
|
+$24.6K |
